HistoMRIFuseNet reports stronger results when it combines confidence-adjusted predictions from independently trained histopathology and breast MRI classifiers—but it does not show how the method performs on paired scans and pathology from the same patients. In the study’s retrospective evaluation, the 1,023 test examples were label-consistent unpaired analysis pairs. That distinction is essential: the reported metrics describe a constructed analysis, not a clinically validated multimodal diagnostic system.
What HistoMRIFuseNet combines
In their 2026 Scientific Reports paper, Himanshu Yadav and Manish Kumar describe a decision-level fusion framework. It combines predictions from two separately trained classifiers: HistoMorphoMamba, which analyzes histopathology images from the BreakHis dataset, and DCE-KineMamba, which estimates lesion risk from BI-RADS-derived features in LA-Breast dynamic contrast-enhanced MRI (DCE-MRI) data. The framework adjusts the models’ output logits using confidence- and quality-related signals, including evidential uncertainty, prediction entropy, and image-quality measures. The paper’s publisher page describes the study and its results.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Sectional Anatomy by MRI and CT | $199.79 | Buy on Amazon |
| 2 |
|
Handbook of MRI Scanning | $54.25 | Buy on Amazon |
| 3 |
|
Human Sectional Anatomy: Pocket atlas of body sections, CT and MRI images, Fourth edition | $56.39 | Buy on Amazon |
| 4 |
|
Sectional Anatomy for Imaging Professionals | $151.72 | Buy on Amazon |
| 5 |
|
Workbook for Sectional Anatomy for Imaging Professionals | $64.42 | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
The classifiers were trained on independent datasets, and the analysis does not assume that a histopathology image and an MRI example belong to the same patient. Instead, the study evaluates label-consistent unpaired analysis pairs. Thus, “fusion” here means combining model outputs under that evaluation design; it does not mean the authors tested a two-modality system on matched patient records.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What the evaluation reports
On 1,023 held-out label-consistent unpaired analysis pairs, the authors report the following results for HistoMRIFuseNet:
#1 Best Overall
| Metric | Reported result |
|---|---|
| Accuracy | 0.9462 |
| F1-score | 0.9535 |
| Matthews correlation coefficient (MCC) | 0.8898 |
| Area under the ROC curve (AUROC) | 0.9786 |
| Area under the precision-recall curve (AUPRC) | 0.9822 |
These are results for the paper’s specified retrospective setup. They should not be read as accuracy, sensitivity, or discrimination measured on a cohort of real patients with both modalities available and matched.
Why the pairing method matters
The study’s comparisons show that how the unpaired examples are combined materially affects the reported performance. Random unpaired fusion falls to 0.7048 accuracy, 0.4052 MCC, and 0.7614 AUROC. By contrast, the strongest validation-tuned weighted-fusion comparison reports 0.9404 accuracy, 0.8635 MCC, and 0.9764 AUROC. Logistic stacking on identical frozen modality outputs reports 0.9410 accuracy, 0.8612 MCC, and 0.9760 AUROC.
Rank #2
The small accuracy and AUROC gaps between HistoMRIFuseNet and those stronger comparisons sit alongside larger differences in MCC and other balanced-classification or calibration measures, according to the authors’ interpretation. The much lower results under random pairing are a further reason not to treat the headline numbers as a general estimate of what pathology-plus-MRI fusion will achieve. Pair construction is part of the result, not a minor implementation detail.
What the study does—and does not—establish
Supported by the reported analysis
- Confidence- and quality-adjusted decision fusion can be evaluated using independently trained pathology and DCE-MRI classifiers without patient-level pairing, provided the analysis defines how examples are combined.
- Within the authors’ label-consistent unpaired evaluation, HistoMRIFuseNet reports high classification and ranking metrics and improves on the reported comparison methods for some measures.
- Performance varies substantially with pair construction, so the evaluation design must accompany any interpretation of the metrics.
Not established by this study
- How the framework performs when each pathology sample and MRI examination are matched to the same patient.
- Whether it improves clinical decisions, patient outcomes, or routine diagnosis.
- Prospective performance in a clinical setting using a common pathology-confirmed reference standard.
The authors identify prospective evaluation on paired histopathology–MRI cohorts with a common pathology-confirmed reference standard as necessary. Until such evidence is available, HistoMRIFuseNet is best understood as a retrospective research framework rather than a validated clinical tool.
Rank #3
How it fits with earlier confidence-based MRI work
A separate 2022 retrospective study examined confidence analysis in a DCE-MRI fusion model for distinguishing malignant from benign breast tumors. It included 130 patients—71 with malignant and 59 with benign tumors—and reported 87.7% accuracy and an AUC of 91.2% ± 4.0% across five-fold testing. That study used a different approach and a single DCE-MRI sequence, so its figures are context rather than a direct benchmark for HistoMRIFuseNet. The 2022 study is indexed by ScienceDirect.
Another single-institution paper evaluated machine learning for breast-cancer diagnosis on MRI using pathology-confirmed cases. It provides additional context for MRI classification research, but does not validate HistoMRIFuseNet. The paper is available through PubMed Central.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Publication details
Yadav and Kumar’s paper was published in Scientific Reports on 8 October 2026, DOI 10.1038/s41598-026-74514-3. The publisher labels the displayed article an early version of accepted research that may be replaced by the final Version of Record. The authors state that they used publicly available, de-identified BreakHis and LA-Breast DCE-MRI datasets; they report no specific funding.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Quick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
